Acurx Pharmaceuticals ACXP
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 4.29 | 4 | -55.34 | -2 | -32.50 | 6 |
| 2025Q2 | 10.22 | 4 | -76.43 | -2 | -40.97 | 6 |
| 2025Q1 | 7.80 | 2 | -146.89 | -2 | -49.61 | 5 |
| 2024Q4 | 16.28 | 1 | -169.69 | -3 | -56.54 | 4 |
| 2024Q3 | 38.00 | 3 | -92.66 | -3 | -44.93 | 6 |
| 2024Q2 | 45.00 | 3 | -87.46 | -4 | -52.55 | 7 |
| 2024Q1 | 49.00 | 6 | -82.09 | -4 | -52.06 | 9 |
| 2023Q4 | 76.60 | 5 | -118.93 | -5 | -68.81 | 8 |
| 2023Q3 | 30.00 | 4 | -61.37 | -3 | -38.00 | 7 |
| 2023Q2 | 53.00 | 6 | -59.77 | -3 | -41.45 | 9 |
| 2023Q1 | 69.20 | 5 | -45.98 | -3 | -34.64 | 7 |
| 2022Q4 | 79.60 | 7 | -38.19 | -3 | -32.09 | 9 |
| 2022Q3 | 60.00 | 10 | -38.19 | -4 | -35.06 | 11 |
| 2022Q2 | 75.80 | 9 | -26.92 | -3 | -25.47 | 9 |
| 2022Q1 | 65.60 | 11 | -23.12 | -3 | -21.73 | 11 |
| 2021Q4 | 86.43 | 12 | -19.69 | -3 | -18.60 | 13 |
| 2021Q3 | 102.80 | 14 | -31.16 | -5 | -28.63 | 15 |
| 2021Q2 | 127.60 | 16 | -44.51 | -4 | -39.21 | 17 |
| 2021Q1 | 2 | -56.99 | -1 | -47.50 | 3 | |
| 2020Q4 | 3 | -1 | 3 |